Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported an 11 percent year-over-year decrease in its fiscal second quarter revenues, which it attributed to a 16 percent drop in diagnostics segment sales.

Separately, the company announced today that it will acquire molecular diagnostics maker GenePOC for up to $120 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.